AIM ImmunoTech Inc.

AMEX: AIM · Real-Time Price · USD
2.52
-0.05 (-1.95%)
At close: Aug 15, 2025, 3:58 PM
2.65
5.16%
After-hours: Aug 15, 2025, 07:30 PM EDT

AIM ImmunoTech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
146K 170K 190K 201K 193K 202K 193K 168K 156K 140K 134K 146K 139K 134K 126K 129K 146K
Cost of Revenue
33K 89K 152K 174K 257K 275K 205K 6.7M 6.67M 6.67M 6.84M 479K 689K 849K 871K 918K 839K
Gross Profit
113K 81K 38K 27K -64K -73K -12K -6.53M -6.52M -6.53M -6.71M -333K -550K -715K -745K -789K -693K
Operating Income
2.12M n/a -27.91M -31.23M -33M -31.56M -23.13M -21.83M -21.07M -19.92M -21.81M -19.22M -18.24M -18.84M -16.54M -15.97M -15.59M
Interest Income
5.12M 5.19M 3.64M 3.21M 951K 1.07M 1.14M 1.02M 783K 629K 296K 124K 96K 123K 211K 280K 275K
Pretax Income
-15.21M -17.32M -23.93M -28.05M -31.12M -28.96M -20.77M -19.34M -19.29M -19.45M -20.9M -18.34M -19.37M -19.13M -17.21M -16.7M -14.19M
Net Income
-15.21M -17.32M -23.93M -28.05M -31.12M -28.15M -19.96M -18.39M -18.49M -20.13M -21.59M -19.17M -20.04M -19.13M -17.21M -16.7M -14.19M
Selling & General & Admin
12.44M 13.66M 20.23M 22.59M 22.55M 21.08M 13.79M 13.52M 13.15M 12.93M 12.04M 8.67M 8.63M 8.67M 8.64M 8.93M 8.5M
Research & Development
5.33M 6.2M 7.72M 9.02M 10.82M 10.93M 9.85M 8.48M 8.01M 6.99M 7.81M 8.44M 7.28M 7.67M 7.02M 6.12M 6.26M
Other Expenses
n/a n/a 15K 15K 343K 598K 583K 911K 583K 328K 328K n/a n/a n/a n/a n/a n/a
Operating Expenses
17.83M 19.91M 27.95M 31.6M 33.37M 32.01M 23.63M 22M 21.15M 19.92M 19.85M 17.11M 15.91M 16.34M 15.66M 15.04M 14.76M
Interest Expense
637K 585K 1.09M 885K 706K 634K n/a n/a n/a n/a n/a 20K 39K 89K 144K 175K 405K
Selling & Marketing Expenses
n/a -58K 9K 9K 9K 67K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.8M 19.94M 28.1M 31.78M 33.53M 32.1M 23.66M 22M 21.22M 20.06M 20.17M 17.59M 16.6M 17.19M 16.53M 15.96M 15.6M
Income Tax Expense
-14.72K n/a 14.72K 8.72K 8.72K -820K -820K -950K -794K 688K 688K 824K 668K n/a n/a n/a n/a
Shares Outstanding (Basic)
70.33M 56.85M 57.68M 52.84M 49.46M 49.1M 48.64M 48.41M 48.4M 48.22M 48.08M 48.03M 47.99M 47.85M 47.85M 47.83M 45.73M
Shares Outstanding (Diluted)
70.33M 56.85M 57.68M 52.84M 49.46M 49.1M 48.64M 48.41M 48.4M 48.22M 48.08M 48.03M 47.99M 47.85M 47.85M 47.83M 45.73M
EPS (Basic)
-0.25 -0.32 -0.48 -0.57 -0.64 -0.58 -0.41 -0.38 -0.38 -0.41 -0.44 -0.39 -0.41 -0.4 -0.36 -0.37 -0.36
EPS (Diluted)
-0.25 -0.32 -0.48 -0.57 -0.64 -0.58 -0.41 -0.38 -0.38 -0.41 -0.44 -0.39 -0.41 -0.4 -0.36 -0.37 -0.36
EBITDA
-14.26M -16.49M -24.66M -29.33M -32.55M -30.45M -20.72M -19.11M -19.11M -18.66M -20.09M -17.24M -18.09M -18.25M -16.27M -15.82M -13.27M
EBIT
-14.57M -16.73M -24.9M -29.56M -32.81M -30.73M -21.12M -19.48M -19.42M -18.91M -20.37M -17.66M -18.66M -19.04M -17.07M -16.52M -13.78M
Depreciation & Amortization
310K 246K 240K 230K 260K 286K 398K 396K 334K 284K 303K 441K 601K 805K 808K 753K 780K